Likewise, interrupting matricellular activation of CD47 enhances liver (Isenberg et al., 2008b) and kidney survival (Rogers et al., 2012) following IRI and ablates pulmonary arterial hypertension in rodents (Bauer et al., 2012). The gene discussed is CD47; the disease is pulmonary arterial hypertension.